KCNJ16 (Potassium Inwardly Rectifying Channel Subfamily J Member 16) encodes Kir5.1, an inwardly rectifying potassium (K+) channel that plays critical roles in neuronal and renal function[@inwardly2010]. Kir5.1 (encoded by KCNJ16) typically forms heteromeric channels with Kir4.1 (encoded by KCNJ10) to create pH-sensitive K+ channels important for maintaining neuronal resting membrane potential, potassium homeostasis, and cellular pH regulation. Genetic variants in KCNJ16 have been associated with altered risk for Alzheimer's disease[@kcnj2019].
The KCNJ16 gene is located on chromosome 17q24.3 and encodes a 427-amino acid protein. Kir5.1 channels conduct K+ ions preferentially in the inward direction (into the cell), helping to maintain the negative resting membrane potential essential for neuronal excitability. The channel is highly sensitive to intracellular pH, with activity increasing under acidic conditions to help regulate cellular pH homeostasis[@yuan2017].
Kir channels are conserved across species:
| Species |
Kir5.1 Homolog |
Identity |
| D. rerio |
kcnj16 |
76% |
| G. gallus |
KCNJ16 |
82% |
| M. musculus |
Kcnj16 |
89% |
| R. norvegicus |
Kcnj16 |
91% |
| H. sapiens |
KCNJ16 |
100% |
| Brain Region |
Expression |
Functional Role |
| Hippocampus |
High |
Synaptic integration |
| Cerebellum |
High |
Motor coordination |
| Cortex |
Moderate |
Cognitive function |
| Basal ganglia |
Moderate |
Movement control |
| Substantia nigra |
Moderate |
PD vulnerability |
| Property |
Value |
| Gene Symbol |
KCNJ16 |
| Full Name |
Potassium Inwardly Rectifying Channel Subfamily J Member 16 |
| Chromosomal Location |
17q24.3 |
| NCBI Gene ID |
3773 |
| Ensembl ID |
ENSG00000186891 |
| UniProt ID |
Q9NP82 |
| OMIM |
613228 |
| Gene Type |
Protein coding |
| Property |
Value |
| Protein Name |
Kir5.1 (inward rectifier K+ channel 5.1) |
| Molecular Weight |
48 kDa |
| Amino Acids |
427 |
| Subcellular Localization |
Plasma membrane |
| Channel Family |
Kir (inwardly rectifying potassium) |
Kir5.1 channels exhibit[@pip2005]:
- Inward rectification: Stronger inward than outward K+ conductance
- pH sensitivity: Activity modulated by intracellular pH
- PIP2 dependence: Requires phosphatidylinositol 4,5-bisphosphate
- Ba2+ block: Blocked by barium ions
| Property |
Value |
Functional Significance |
| Single-channel conductance |
30 pS |
Moderate conductance |
| Inward rectification |
Strong |
Voltage dependence |
| pH sensitivity |
pKa ~ 7.0 |
pH regulation |
| PIP2 requirement |
High |
Metabolic regulation |
Kir5.1 primarily forms heteromeric channels with Kir4.1:
| Combination |
Properties |
| Kir5.1/Kir4.1 |
pH-sensitive, brain-expressed |
| Kir5.1/Kir4.1 (renal) |
pH-sensitive, kidney-expressed |
| Kir5.1 homomeric |
Less common |
Kir5.1 dysfunction may contribute to AD through[@patel2018]:
- Impaired neuronal K+ homeostasis
- Altered synaptic plasticity
- Increased neuronal excitability
- Dysregulated pH in neurons
flowchart TD
A["KCNJ16 variant"] --> B["Reduced channel function"]
B --> C["Impaired K+ clearance"]
C --> D["Neuronal depolarization"]
D --> E["Excitotoxicity"]
D --> F["Synaptic dysfunction"]
E --> G["Cognitive decline"]
F --> G
In PD, Kir channels play roles in[@schram2019]:
- Dopaminergic neuron survival
- Mitochondrial function
- Oxidative stress response
K+ channel dysfunction contributes to epilepsy[@potassium2012]:
- impaired inhibitory control
- Neuronal hyperexcitability
- Seizure generation
| Domain |
Residues |
Function |
| N-terminus |
1-70 |
PIP2 binding |
| Transmembrane 1 |
71-95 |
Pore helix |
| Pore loop |
140-170 |
Selectivity filter |
| Transmembrane 2 |
195-220 |
Gate |
| C-terminus |
221-427 |
Regulatory domains |
- PIP2 binding: Required for channel opening
- pH sensing: His204 reports pH
- Gate closure: Intracellular gate via M84, M206
- Block: Ba2+ block from intracellular side
| Variant |
Effect |
Disease Association |
| rs12926049 |
Promoter |
AD risk |
| rs2273604 |
Non-coding |
PD risk |
| c. 514G>A |
Missense |
Renal tubular acidosis |
| Approach |
Agent |
Stage |
| Channel openers |
Retigabine |
Research |
| Gene therapy |
AAV-KCNJ16 |
Preclinical |
| pH modulators |
Small molecules |
Research |
flowchart TD
subgraph Channels
A["KCNJ16"] --> B["KCNJ10 (Kir4.1)"]
A --> C["KCNJ2"]
end
subgraph Signaling
A --> D["PIP2"]
A --> E["pH"]
end
subgraph Disease
A --> F["AD genes"]
A --> G["PD genes"]
end
| Protein |
Interaction |
Function |
| KCNJ10 |
Heteromer |
Brain K+ channels |
| PIP2 |
Cofactor |
Channel activation |
| Intracellular pH |
Modulator |
Activity regulation |
| ATP |
Modulator |
Metabolic coupling |
| Biomarker |
Disease |
Change |
| KCNJ16 expression |
AD |
Reduced 30% |
| KCNJ16 expression |
PD |
Variable |
| Kir5.1 current |
AD |
Reduced |
- Retigabine: Kir channel opener
- Flavonoids: Natural channel modulators
- Riluzole: Indirect modulators
- Hibino et al., Inwardly rectifying potassium channels (2010)
- Baukrowitz et al., PIP2 as a signaling molecule (2005)
- Jentsch TJ, Neuronal KCNQ potassium channels (2000)
- Greka et al., KCNJ2/Kir2.1 channelopathy (2011)
- Narducci et al., KCNJ15 and Alzheimer's disease (2019)
- Schulte et al., Mitochondrial KATP channel (2012)
- Cooper EC, Potassium channels and epilepsy (2012)
- Brown et al., Neuronal K+ channels (2006)
- Fakih et al., Kir5.1 in renal bicarbonate handling (2015)
- Yuan et al., Kir5.1 in neuronal pH regulation (2017)
- Patel et al., Potassium channels in neurodegeneration (2018)
- Schram et al., Kir channels and synaptic function (2019)
- Tadross MR, Kir channel pharmacology (2010)
- Zhang et al., Kir channels in Alzheimer's disease (2016)
- Kourpopoulos et al., Inward rectifiers in neuronal signaling (2016)
- Hibino et al., Kir channels in cell physiology (2011)
- Yang et al., pH sensitivity of Kir channels (2018)
- Liu et al., Kir5.1 mutations and disease (2019)
- Chen et al., Kir channel modulators in therapy (2020)
- Shieh et al., Potassium channels as drug targets (2022)